throughout
histori
infecti
diseas
caus
virus
pose
seriou
threat
human
popul
worldwid
recent
time
ebola
viru
caus
death
africa
peopl
infect
middl
east
respiratori
syndrom
coronaviru
south
korea
illustr
devast
effect
virus
intern
commun
influenza
caus
agent
influenza
bird
also
lead
highli
infecti
respiratori
diseas
mammal
viral
genom
mutat
antigen
drift
period
gene
segment
reassort
human
anim
antigen
shift
result
emerg
new
viral
pathogen
potenti
caus
seriou
pandem
past
year
pandem
influenza
occur
sever
pandem
result
approxim
million
death
worldwid
recent
pandem
swine
flu
pandem
emerg
countri
caus
death
accord
world
health
organ
report
highli
pathogen
avian
influenza
first
identifi
hong
kong
high
pathogen
strain
lack
host
protect
immun
virus
continu
threaten
live
effect
infect
control
measur
crucial
prevent
seriou
outbreak
viral
particl
releas
infect
patient
cough
sneez
surviv
prolong
period
air
surfac
viral
transmiss
occur
direct
persontoperson
contact
uptak
contamin
airborn
droplet
contact
contamin
surfac
use
antivir
materi
effect
way
inactiv
viral
particl
environ
prevent
viral
transmiss
therebi
lower
risk
infect
purpos
solidst
inorgan
compound
metal
oxid
good
candid
chemic
robust
feasibl
use
coat
materi
copper
silver
recogn
biocid
properti
sinc
ancient
time
howev
unlik
ionic
form
cu
ag
biocid
properti
solidst
copper
silver
compound
cuo
cu
ag
poorli
solubl
water
remain
fulli
elucid
recent
report
solidst
copper
compound
includ
copper
oxid
cu
sulfid
cu
iodid
cui
effici
inactiv
bacteriophag
bacteria
inactiv
bacteriophag
mainli
mediat
direct
contact
solidst
copper
compound
rather
exposur
reactiv
oxygen
speci
leach
copper
ion
investig
antivir
activ
four
group
compound
solidst
copper
compound
cu
cuo
copper
ionic
compound
cucl
solidst
silver
compound
ag
silver
ionic
compound
agno
ag
pathogen
influenza
viru
bacteriophag
effect
compound
surfac
protein
influenza
virus
hemagglutinin
ha
neuraminidas
na
also
investig
reveal
mechanist
insight
viral
inactiv
compound
cuprou
copper
silver
compound
obtain
wako
pure
chemic
tokyo
japan
diamet
particl
rang
cuprou
oxid
cu
cupric
oxid
cuo
silver
sulfid
ag
measur
bet
surfac
area
cu
cuo
ag
particl
g
respect
ethanol
suspens
compound
particl
uniformli
spread
glass
slide
cm
cm
follow
heat
c
h
steril
particl
spread
mol
metal
copper
silver
correspond
gm
cu
gm
cuo
gm
ag
gm
ag
although
ag
moder
watersolubl
glass
sampl
prepar
procedur
solidst
compound
case
watersolubl
compound
cucl
agno
dri
particl
gm
cucl
gm
agno
ethanol
solut
glass
substrat
room
temperatur
use
avoid
oxid
heat
treatment
human
influenza
viru
refer
strain
use
studi
purchas
american
type
cultur
collect
manassa
va
usa
viral
propag
embryon
chicken
egg
inocul
viru
incub
c
h
chill
c
h
viru
harvest
harvest
viru
particl
purifi
concentr
use
combin
depth
filter
polypropylen
depth
filter
ge
infrastructur
usa
membran
filter
polypropylen
mesh
microfiltr
crossflow
ultrafiltr
polysulfon
hollowfib
filter
cutoff
ge
infrastructur
usa
previous
describ
concentr
viru
particl
purifi
sucros
densiti
gradient
centrifug
use
linear
sucros
gradient
purifi
sampl
contain
mgml
protein
determin
biorad
protein
assay
biorad
laboratori
hercul
ca
usa
viru
stock
store
c
experiment
manipul
viral
stock
thaw
titer
assay
describ
l
experiment
sampl
place
presteril
centrifug
tube
experiment
sampl
adjust
mgml
protein
supplement
bovin
serum
albumin
stabil
prior
perform
measur
bacteriophag
nbrc
also
use
evalu
antivir
activ
copper
silver
compound
stock
viral
suspens
prepar
accord
previou
report
suspens
bacteriophag
mix
escherichia
coli
nbrc
cell
c
min
mixtur
plate
onto
agar
medium
form
doubl
agar
layer
overnight
incub
c
bacteriophag
top
agar
layer
extract
sm
buffer
nacl
mm
mgso
mm
trishcl
ph
gelatin
c
overnight
extract
solut
centrifug
g
c
min
supernat
collect
filter
use
millex
filter
millipor
usa
stock
suspens
bacteriophag
store
c
prior
use
evalu
experi
evalu
effect
compound
influenza
viru
bacteriophag
viral
suspens
inocul
onto
sampl
glass
slide
room
temperatur
incub
dark
time
rang
min
h
incub
virus
harvest
shake
plastic
case
mm
phosphatebuff
salin
pb
buffer
influenza
viru
titrat
use
madindarbi
canin
kidney
cell
tissu
cultur
infect
dose
tcid
ml
determin
accord
method
reed
muench
viral
titer
bacteriophag
also
determin
number
plaqu
form
use
doublelay
method
describ
denatur
ha
exposur
cu
cuo
agno
ag
investig
twentyf
microlit
purifi
ha
ngl
abcam
cambridg
uk
mix
equal
volum
copper
silver
compound
suspens
incub
dark
room
temperatur
solid
remov
centrifug
g
min
use
ultrafre
tube
millipor
hemagglutinin
sampl
serial
dilut
micropl
mix
l
chicken
red
blood
cell
nihon
bd
tokyo
japan
wash
pb
ha
titer
determin
calcul
reciproc
highest
dilut
ha
well
complet
hemagglutin
na
activ
also
evalu
use
standard
protocol
nastar
method
appli
biosystem
foster
citi
ca
usa
eighti
microlit
neuraminidas
ngl
new
england
biolab
beverli
usa
mix
l
suspens
copper
silver
compound
incub
dark
room
temperatur
solid
remov
centrifug
use
ultrafre
tube
millipor
ten
microlit
nastar
substrat
ad
l
na
sampl
triplic
sampl
incub
room
temperatur
min
l
enhanc
ad
chemiluminesc
measur
use
micropl
reader
corona
electr
co
ltd
ibaraki
japan
investig
influenc
cystein
residu
protein
cu
cuo
ag
ag
particl
solut
cucl
agno
mmol
mix
g
trypsin
inhibitor
protein
phosphat
buffer
ph
incub
h
room
temperatur
solid
precipit
centrifug
l
filtrat
mix
l
dithiothreitol
h
incub
room
temperatur
l
monobromobiman
ad
mixtur
incub
min
room
temperatur
fluoresc
nm
excit
nm
measur
use
micropl
reader
infinit
tecan
japan
co
ltd
kawasaki
japan
sampl
measur
triplic
accord
previou
studi
biocid
activ
solidst
copper
compound
deriv
surfac
contact
solid
thu
antivir
activ
two
type
virus
differ
surfac
structur
influenza
viru
bacteriophag
surfac
solidst
copper
silver
compound
evalu
influenza
viru
possess
viral
envelop
cell
membranelik
structur
encas
central
core
bacteriophag
lack
envelop
instead
surfac
compos
protein
capsid
two
viral
suspens
inocul
onto
glass
slide
load
cu
cuo
particl
incub
specifi
time
period
virus
harvest
viral
titer
evalu
determin
tcid
ml
fig
titer
influenza
viru
drastic
decreas
contact
cu
particl
order
magnitud
min
exposur
mol
copper
amount
log
nn
contrast
cuoload
sampl
show
reduct
log
nn
influenza
viral
titer
min
exposur
indic
signific
differ
antivir
activ
differ
oxid
state
copper
oxid
borkow
et
al
report
copper
oxideimpregn
face
mask
larg
inactiv
human
influenza
avian
influenza
viru
log
nn
within
min
sinc
oxid
state
copper
discrimin
paper
result
suggest
activ
compound
materi
would
cu
case
copper
compound
previou
studi
report
exposur
metal
copper
surfac
inactiv
influenza
viru
order
magnitud
h
four
order
h
hand
studi
antiinfluenza
activ
cu
ii
ion
reveal
viru
titer
decreas
two
order
magnitud
h
even
high
concentr
anoth
studi
imai
et
al
report
purifi
influenza
virus
inactiv
fold
reduct
h
treatment
high
concentr
among
copper
compound
solidst
cu
appear
effect
inhibitori
agent
influenza
viru
similar
find
observ
nonenvelop
bacteriophag
fig
fact
titer
bacteriophag
decreas
six
order
magnitud
min
incub
cu
particl
log
nn
wherea
cuo
particl
cu
ii
ion
littl
effect
viral
titer
log
nn
cuo
cucl
respect
result
show
solidst
cuprou
compound
sharp
contrast
solidst
cupric
compound
cupric
ion
highli
effect
inactiv
virus
regardless
viral
envelop
next
inactiv
influenza
viru
bacteriophag
silver
compound
investig
fig
agno
high
aqueou
solubl
ag
moder
aqueou
solubl
gl
markedli
decreas
titer
influenza
viru
log
nn
min
exposur
agno
ago
respect
min
exposur
contrast
ag
insolubl
water
show
decreas
viral
titer
log
nn
min
exposur
result
indic
decreas
influenza
viral
titer
depend
solubl
silver
ion
compound
exposur
ag
agno
ag
inactiv
bacteriophag
three
log
nn
two
log
nn
one
log
nn
order
magnitud
within
min
respect
fig
sever
studi
also
show
strong
antiinfluenza
effect
silver
nanoparticl
seem
similar
find
compar
influenza
viru
inactiv
bacteriophag
ag
agno
decreas
slowli
indic
watersolubl
silver
compound
agno
ag
effect
nonenvelop
viru
furthermor
insolubl
silver
compound
ag
unabl
inactiv
either
viru
result
impli
differ
inactiv
mechan
exist
influenza
bacteriophag
virus
respons
exposur
silver
compound
studi
purifi
viral
suspens
use
evalu
inactiv
effect
among
copper
silver
compound
robust
condit
affect
protein
content
protein
amount
extract
condit
hand
would
use
evalu
antivir
activ
use
crude
viral
suspens
applic
materi
real
environ
thu
evalu
antivir
activ
cu
influenza
viru
contain
mgml
bovin
serum
albumin
bsa
includ
protein
amount
allanto
fluid
mgml
influenza
virus
exposur
cu
inactiv
presenc
mgml
bsa
wherea
viral
inactiv
effici
significantli
decreas
log
nn
mgml
bsa
respect
min
exposur
increas
amount
coexist
protein
similar
tendenc
found
antiinfluenza
activ
anoth
metal
oxid
materi
tio
result
suggest
inactiv
effici
copper
silver
compound
would
affect
coexist
protein
antivir
activ
real
environ
would
lower
control
laboratori
condit
explain
differ
inactiv
effect
copper
silver
compound
influenza
viru
focus
viral
surfac
protein
highli
involv
infect
process
influenza
viru
express
hundr
ha
na
protein
surfac
envelop
ha
glycosyl
lectin
protein
recogn
sialic
acid
residu
receptor
protein
host
cell
influenza
virus
bind
hasial
acid
interact
enter
host
cell
endocytosi
na
endoglycosidas
necessari
releas
virus
surfac
host
cell
also
involv
initi
influenza
infect
protein
play
import
role
establish
spread
influenza
infect
determin
ha
activ
treatment
copper
compound
purifi
protein
incub
cu
cuo
suspens
concentr
antivir
evalu
experi
remov
solid
particl
filtrat
sampl
mix
chicken
red
blood
cell
treatment
cu
drastic
decreas
ha
titer
ha
titer
fell
detect
limit
within
min
contrast
ha
titer
treatment
cuo
chang
min
fig
highli
sensit
detect
na
activ
deriv
sialic
acid
nastar
use
chemiluminesc
substrat
shown
fig
cu
otreat
na
show
larg
decreas
chemiluminesc
min
contrast
treatment
cuo
affect
activ
na
even
min
exposur
fig
result
indic
hemagglutin
abil
ha
enzymat
activ
na
disrupt
incub
cu
particl
correspond
inactiv
rate
influenza
virus
cu
oload
glass
substrat
therefor
loss
ha
na
function
follow
exposur
cu
inactiv
abil
influenza
virus
infect
host
cell
next
activ
ha
na
exposur
cu
agno
ag
determin
differ
metal
concentr
exposur
cu
decreas
ha
titer
lower
metal
concentr
two
silver
compound
agno
ag
fig
addit
ha
activ
significantli
decreas
rang
cu
concentr
mol
wherea
na
activ
affect
condit
fig
b
differ
dose
respons
ha
na
activ
suggest
influenza
viru
inactiv
solidst
cu
low
concentr
mainli
origin
inhibit
ha
protein
exposur
silver
ionic
compound
na
activ
lost
lower
metal
concentr
observ
cu
fig
suggest
silver
ionic
compound
inactiv
viru
preferenti
lose
enzym
activ
na
imai
et
al
report
treatment
cu
contain
zeolit
decreas
na
activ
affect
ha
titer
similar
tendenc
find
silver
ionic
compound
furthermor
ask
whether
structur
viral
protein
would
destabil
contact
copper
silver
compound
evalu
total
thiol
r
sh
concentr
disulfid
bond
cystein
residu
disulfid
bond
format
essenti
protein
fold
mainten
structur
function
protein
like
protein
ha
na
protein
possess
multipl
disulfid
bond
stabil
structur
previou
report
detail
method
determin
total
concentr
thiol
evalu
fluoresc
monobromobiman
use
trypsin
inhibitor
protein
possess
two
bond
one
cystein
residu
per
molecul
model
protein
shown
fig
cuo
ag
inactiv
influenza
viru
bacteriophag
affect
thiol
concentr
contrast
copper
ion
cucl
silver
ion
agno
ag
clearli
decreas
thiol
trypsin
inhibitor
protein
suggest
copper
silver
ion
denatur
protein
breakag
bond
accord
follow
reaction
r
r
ag
ag
r
sh
ag
r
ag
h
r
r
cu
r
cu
r
sh
cu
r
cu
r
r
r
r
sh
repres
disulfid
bond
cystein
residu
trypsin
inhibitor
protein
ag
cu
form
end
reaction
fluoresc
gener
reaction
sh
monobromobiman
hardli
detect
tabl
summar
antivir
activ
test
compound
influenza
viru
bacteriophag
effect
function
structur
viral
protein
copper
silver
ion
cucl
agno
ag
inactiv
influenza
virus
also
inhibit
na
enzym
activ
low
concentr
indic
biocid
activ
ionic
compound
mainli
mediat
na
inhibit
addit
ion
abl
induc
protein
destabil
breakag
bond
disrupt
disulfid
bond
na
may
result
loss
enzymat
activ
mutat
cystein
residu
na
report
tabl
summari
antivir
activ
copper
silver
compound
influenza
viru
bacteriophag
denatur
ha
na
protein
significantli
impair
enzym
activ
contrast
solid
state
cu
inactiv
virus
without
viral
envelop
influenza
viru
bacteriophag
preferenti
inhibit
ha
activ
ha
involv
host
cell
recognit
ligandreceptor
interact
cell
surfac
previou
studi
reveal
major
biocid
effect
cu
mediat
virus
come
direct
contact
metalco
solid
surfac
thu
direct
contact
protein
cu
would
caus
structur
denatur
ha
result
impair
ligandreceptor
recognit
idea
support
effici
inactiv
mediat
solidst
cu
bacteriophag
viru
possess
capsid
protein
surfac
instead
viral
envelop
like
ha
inactiv
denatur
surfac
protein
bacteriophag
inhibit
infect
host
bacteria
inactiv
effect
distinct
observ
ionic
copper
silver
compound
studi
denatur
protein
structur
partial
caus
cleavag
bond
howev
cu
decreas
thiol
concentr
approxim
half
despit
high
antivir
activ
weaker
effect
ionic
copper
silver
compound
result
suggest
cu
denatur
protein
structur
mechan
disord
hydrogen
bind
network
ionic
interact
protein
surfac
found
signific
differ
protein
adsorpt
denatur
cu
cuo
might
caus
opposit
antivir
activ
although
interact
protein
solid
surfac
studi
effect
solidst
cu
viral
protein
structur
follow
direct
contact
requir
clarif
conclus
evalu
viral
activ
respons
exposur
copper
silver
compound
demonstr
antivir
mechan
metal
influenza
virus
mediat
inactiv
ha
na
surfac
protein
compar
analysi
compound
reveal
antivir
effect
cu
significantli
differ
ionic
copper
silver
compound
respect
influenza
viru
one
major
strategi
control
viru
transmiss
vaccin
howev
vaccin
typic
effect
newli
emerg
virus
owe
lack
suitabl
target
antigen
inhibitor
na
oseltamivir
tamiflu
zanamivir
relenza
also
current
use
antiinfluenza
drug
despit
report
efficaci
like
influenza
virus
gradual
develop
resist
drug
combin
current
strategi
util
inorgan
chemic
contain
copper
silver
antiinfluenza
materi
would
potenti
reduc
risk
viral
transmiss
environ
particular
solidst
cu
superior
activ
type
virus
envelop
nonenvelop
compar
silver
compound
uniqu
inactiv
mechan
mediat
direct
contact
furthermor
cu
lowcost
wide
avail
surfac
coat
agent
variou
materi
surfac
airclean
filter
cu
also
combin
biocid
coat
chemic
photocatalyt
tio
nanoparticl
use
cu
treatment
public
live
space
may
help
limit
even
prevent
futur
influenza
pandem
